Next-generation therapeutics
Radiopharmaceuticals, RNA medicines and differentiated therapeutic platforms addressing significant unmet medical needs.
HealthVentures
HealthWe partner with ambitious healthcare companies at pivotal moments, connecting specialist capital, operating expertise and a global network to accelerate progress.
Discover our approach ↘The next generation of healthcare companies needs more than funding. It needs people who understand the science, the decisions ahead and the work required to turn potential into meaningful progress.
Yaday Health Ventures is an operator-led healthcare investment platform. We focus on acceleration-stage biotech and medtech companies approaching important clinical, commercial and strategic milestones.
Scientific, clinical and commercial diligence focused on the evidence that matters, and the milestones that can change a company's trajectory.
Active engagement through board or observer participation, operating partners and focused acceleration plans.
Connecting innovation from Europe and Israel with expertise, partnerships and opportunities in the United States.
We seek differentiated platforms with a compelling scientific foundation, a clear unmet need and an actionable next stage of development.
Radiopharmaceuticals, RNA medicines and differentiated therapeutic platforms addressing significant unmet medical needs.
Tools and platforms bringing computation to drug discovery, therapeutic design, diagnostics and precision medicine.
Medical devices, surgical innovation and technologies with the potential to reshape care delivery and patient outcomes.
A specialist investment approach spanning a fund strategy and selective company-specific opportunities.
A fund strategy designed to build exposure across a select group of healthcare companies, supported by a shared diligence process and active ownership.
Connect with our team ↗Dedicated vehicles that give qualified investors direct access to selected healthcare companies, alongside our own capital and on the same diligence standards.
Connect with our team ↗We work with founders well beyond the investment, through board involvement, introductions and hands-on support at the moments that shape a company's trajectory.
Connect with our team ↗The fund strategy and SPVs are separate investment vehicles. Participation is subject to eligibility, availability and definitive offering documents.
Yaday Health joined WhiteLab Genomics' $26 million Series B, supporting a company using AI to advance the design of genomic medicines. Daniel Teper joined its board.
Healthcare innovation is global. We connect founders, specialist investors and operating expertise across the United States, Europe and Israel.
As part of the broader Yaday ecosystem, our healthcare focus brings a specialist lens to a network built around entrepreneurs and opportunity.
Explore the Yaday ecosystem ↗Complementary perspectives across healthcare company building, investing and international networks.
PharmD, MBA. Healthcare entrepreneur and founder and CEO of NAYA Therapeutics, bringing scientific, clinical and company-building experience to the investment process.
LinkedIn ↗
Entrepreneur and founder of Yaday Capital, bringing international relationships, capital formation and strategic partnership expertise.
LinkedIn ↗For founders advancing healthcare and investors who share our conviction in its future.